MaxCyte (MXCT) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
MaxCyte, Inc. has announced a change in major holdings as BlackRock, Inc. now holds 8.52% of the company’s voting rights, following a recent acquisition. This development is significant for investors tracking major moves in the biotech sector, as it may influence MaxCyte’s strategic decisions and market performance.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
